Olmesartan Medoxomil
DEVELOPMENT OF AGGLOMERATED CRYSTALS OF OLMESARTAN MEDOXOMIL BY SPHERICAL CRYSTALIZATION TECHNIQUE FOR ENHANCING THE MICROMERITIC AND SOLUBILITY PROPERTY
30
VALIDATED REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD FOR SIMULTANEOUS ESTIMATION OF OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE AND AMLODIPINE BESYLATE IN NEWLY DESIGNED PHARMACEUTICAL DOSAGE FORM
5
STABILITY INDICATING RP-HPLC METHOD FOR THE SIMULTANEOUS DETERMINATION OF OLMESARTAN MEDOXOMIL AND ATORVASTATIN CALCIUM
6
Central composite design for validation of hptlc method for simultaneous estimation of olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide in tablets
9
RP HPLC METHOD FOR SIMULTATANEOUS DETERMINATION OF ATORVASTATIN CALCIUM, OLMESARTAN MEDOXOMIL, CANDESARTAN, HYDROCHLOROTHIAZIDE AND CHLORTHALIDONE – APPLICATION TO COMMERCIALLY AVAILABLE DRUG PRODUCTS
9
Integrated control of hypertension by olmesartan medoxomil and hydrochlorothiazide and rationale for combination
11
FORMULATION DEVELOPMENT AND OPTIMIZATION OF OLMESARTAN MEDOXOMIL IMMEDIATE RELEASE TABLETS
6
PREPARATION AND CHARATEIZATION OF OLMESARTAN MEDOXOMIL SOLID DISPERSION FOR THE DEVELOPMENT OF ORODISPERSABLE TABLETSO. Kumar*, A. Prameela Rani and V. SaikishoreDOWNLOAD/VIEW/http://doi.org/10.5281/zenodo.192352
7
Critical appraisal of amlodipine and olmesartan medoxomil fixed-dose combination in achieving blood pressure goals
14
ENHANCEMENT OF SOLUBILITY AND DISSOLUTION RATE OF OLMESARTAN MEDOXOMIL USING SYLYSIA
9
Efficacy study of olmesartan medoxomil on coronary atherosclerosis progression and epicardial adipose tissue volume reduction in patients with coronary atherosclerosis detected by coronary computed tomography angiography: study protocol for a randomized controlled trial
8
Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: OLmesartan rosuvaSTAtin from Daewoong)
11
Direct Compression Suitability of Olmesartan Medoxomil and Amlodipine Besylate Using Sedem Diagram
118
Simultaneous estimation of amlodipine besilate and olmesartan medoxomil in pharmaceutical dosage form
5
Effect of angiotensin receptor blockade on endothelial function: focus on olmesartan medoxomil
14
DEVELOPMENT AND VALIDATION OF A REVERSED PHASE HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE IN COMBINED TABLET DOSAGE FORM
5
Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil
12
Development of Validation of RP – HPLC Method, UV – Spectrophotometric Simultaneous Equation Method Of Drotaverine Hydrochloride and Mefenamic Acid in Combined Tablet Dosage From. Development and Validation of RP – HPLC Method, Uv – Spectrophotometric Simultaneous Equation Method of Olmesartan Medoxomil and Hydrochlorothiazide in Combined Tablet Dosage Form.
147
Development and Validation of Stability Indicating LC Method for Olmesartan Medoxomil
8
QUANTITATIVE DETERMINATION AND VALIDATION OF OLMESARTAN MEDOXOMIL IN PHARMACEUTICAL USING QUANTITATIVE NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
26